Skip to main content
Caplight Logo









Flow Pharma, Inc.

Flow Pharma, Inc.

Private
Warrensville Heights, OhioHealthcare & Life Scienceshttps://flowpharma.com/

Last Round

Grant

May 13, 2020

Total Funding Raised

$1.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Flow Pharma, Inc. is a biotechnology company that develops T-cell based vaccine delivery platforms and immunotherapies for the treatment and prevention of cancer and viral diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

immunotherapyvaccine platformneoantigenprecision medicinedrug discoveryAI drug discoveryin silico drug designbiotechnologybiodefenseSBIRSTTRpersonalized medicinecomputational biologyclinical-stage biotechAI biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flow Pharma, Inc. Comparables

Compare Flow Pharma, Inc. with similar companies based on industry and business-model similarity.

Flow Pharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gritstone bio
79%
PDS Biotechnology Corp
77%
PathoVax LLC
73%

Flow Pharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 13, 2020
SeedSep 25, 2018

Key People

Founding team and executive leadership

Reid Rubsamen

Founder CEO Board Member

Founding Team

Flow Pharma, Inc. Investors

Notable investors and investment history

Flow Pharma, Inc. investors
InvestorRounds
United States Department of DefenseGrant
Button CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 31% MoM, reaching 2.2K.

  • Jul 28, 2026

    Monthly visitors increased 140% MoM.

Flow Pharma, Inc. Filings

Explore SEC and related filing metadata, where available.

Flow Pharma, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Flow Pharma, Inc.'s valuation, stock price, and market status.

Is Flow Pharma, Inc. a public or private company?

Flow Pharma, Inc. is a private company.

What is the current stock price of Flow Pharma, Inc.?

Flow Pharma, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Flow Pharma, Inc. worth (valuation)?

Valuation information for Flow Pharma, Inc. is not publicly available.

Can I buy Flow Pharma, Inc. stock?

Flow Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Flow Pharma, Inc.'s last funding round?

Flow Pharma, Inc.'s most recent funding round was Grant on May 13, 2020.

Who are the main investors in Flow Pharma, Inc.?

Key investors in Flow Pharma, Inc. include United States Department of Defense, Button Capital.

Will Flow Pharma, Inc. IPO soon?

No public IPO plans have been announced for Flow Pharma, Inc..

How can I track Flow Pharma, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Flow Pharma, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWarrensville Heights, Ohio
Employee Range9
Year Founded1999
Last FundingMay 13, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?